Compounds > 1-(5-isoquinolinesulfonyl)-2-methylpiperazine

1-(5-isoquinolinesulfonyl)-2-methylpiperazine and 2',3'-dialdehyde atp

1-(5-isoquinolinesulfonyl)-2-methylpiperazine has been researched along with 2',3'-dialdehyde atp in 8 studies

Research

Studies (8)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (12.50)18.2507
2000's7 (87.50)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chessell, IP; Grahames, CB; Humphrey, PP; Michel, AD1
Chessell, IP; Humphrey, PP; Kaur, R; Michel, AD1
Chiozzi, P; Di Virgilio, F; Dichmann, S; Ferrari, D; Idzko, M; Luttmann, W; Norgauer, J; Purlis, D; Virchow, C1
Kimura, J; Matsuoka, I; Watano, T1
Duncan, M; Elssner, A; Gavrilin, M; Wewers, MD1
Adinolfi, E; Baricordi, OR; Chiozzi, P; Di Virgilio, F; Morelli, A; Rizzo, R; Solini, A1
Adinolfi, E; Baricordi, R; Di Virgilio, F; Falzoni, S; Ferrari, D; Forchap, S; Minelli, M; Pizzirani, C; Sitta, B; Turchet, L1
An, D; Chen, J; He, B; Li, M; Liu, P; Meng, L; Zhang, X; Zhang, Y; Zhao, J1

Other Studies

8 other study(ies) available for 1-(5-isoquinolinesulfonyl)-2-methylpiperazine and 2',3'-dialdehyde atp

ArticleYear
Pharmacological characterization of ATP- and LPS-induced IL-1beta release in human monocytes.
    British journal of pharmacology, 1999, Volume: 127, Issue:8

    Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Adenosine Triphosphate; Cell Line; Enzyme Inhibitors; Humans; Interleukin-1; L-Lactate Dehydrogenase; Lipopolysaccharides; Monocytes; Purinergic P2 Receptor Antagonists; Pyridoxal Phosphate; Receptors, Purinergic P2; Receptors, Purinergic P2X7

1999
Antagonist effects on human P2X(7) receptor-mediated cellular accumulation of YO-PRO-1.
    British journal of pharmacology, 2000, Volume: 130, Issue:3

    Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Adenosine Triphosphate; Antibodies, Blocking; Benzoxazoles; Calcium-Calmodulin-Dependent Protein Kinases; Cell Line; Enzyme Inhibitors; Fluorescent Dyes; Humans; Imidazoles; In Vitro Techniques; Purinergic P2 Receptor Antagonists; Pyridoxal Phosphate; Quinolinium Compounds; Receptors, Purinergic P2X7; Stimulation, Chemical

2000
P2 purinergic receptors of human eosinophils: characterization and coupling to oxygen radical production.
    FEBS letters, 2000, Dec-15, Volume: 486, Issue:3

    Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Adenosine Triphosphate; Calcium; Chelating Agents; Complement C5a; Dose-Response Relationship, Drug; Enzyme Inhibitors; Eosinophils; Guanosine Triphosphate; Humans; Intracellular Fluid; Purinergic P2 Receptor Agonists; Purinergic P2 Receptor Antagonists; Reactive Oxygen Species; Receptors, Purinergic P2; Uridine Triphosphate

2000
Characteristics of ATP-induced current through P2X7 receptor in NG108-15 cells: unique antagonist sensitivity and lack of pore formation.
    Japanese journal of pharmacology, 2002, Volume: 88, Issue:4

    Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Adenosine Triphosphate; Animals; Benzoxazoles; Cations; Cell Membrane Permeability; Fluorescent Dyes; Mice; Patch-Clamp Techniques; Purinergic P2 Receptor Antagonists; Pyridoxal Phosphate; Quinolinium Compounds; Rats; Receptors, Purinergic P2; Receptors, Purinergic P2X7; Suramin; Triazines; Tumor Cells, Cultured

2002
A novel P2X7 receptor activator, the human cathelicidin-derived peptide LL37, induces IL-1 beta processing and release.
    Journal of immunology (Baltimore, Md. : 1950), 2004, Apr-15, Volume: 172, Issue:8

    Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Adenosine Triphosphate; Antimicrobial Cationic Peptides; Apyrase; Binding Sites; Caspase 1; Cathelicidins; Cell Membrane Permeability; Cells, Cultured; Enzyme Activation; Humans; Interleukin-1; Lipopolysaccharides; Monocytes; Protein Processing, Post-Translational; Purinergic P2 Receptor Antagonists; Receptors, Formyl Peptide; Receptors, Lipoxin; Receptors, Purinergic P2; Receptors, Purinergic P2X7

2004
Enhanced P2X7 activity in human fibroblasts from diabetic patients: a possible pathogenetic mechanism for vascular damage in diabetes.
    Arteriosclerosis, thrombosis, and vascular biology, 2004, Volume: 24, Issue:7

    Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Adenosine Diphosphate; Adenosine Triphosphate; Apoptosis; Apyrase; Autocrine Communication; Cell Shape; Cytidine Triphosphate; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Fibroblasts; Fibronectins; Gene Expression Regulation; Humans; Interleukin-6; Membrane Potentials; Paracrine Communication; Pyridoxal Phosphate; Receptors, Purinergic P2; Receptors, Purinergic P2X7; Uridine Diphosphate; Uridine Triphosphate

2004
The antibiotic polymyxin B modulates P2X7 receptor function.
    Journal of immunology (Baltimore, Md. : 1950), 2004, Oct-01, Volume: 173, Issue:7

    Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Adenosine Triphosphate; Amino Acid Sequence; Animals; Anti-Bacterial Agents; Calcium; Cell Line; Cell Line, Tumor; Cell Survival; Dose-Response Relationship, Drug; Drug Synergism; Ethidium; Humans; Intracellular Fluid; K562 Cells; Leukemia, Lymphocytic, Chronic, B-Cell; Macrophages; Mice; Molecular Sequence Data; Oxidation-Reduction; Polymyxin B; Purinergic P2 Receptor Antagonists; Rats; Receptors, Purinergic P2; Receptors, Purinergic P2X7; Transfection

2004
The role of P2X7 receptor in ATP-mediated human leukemia cell death: calcium influx-independent.
    Acta biochimica et biophysica Sinica, 2009, Volume: 41, Issue:5

    Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Adenosine Triphosphate; Apoptosis; Benzoxazoles; Biological Transport; Calcium; Cell Line, Tumor; Cell Survival; Dose-Response Relationship, Drug; Flow Cytometry; Humans; Leukemia; Purinergic P2 Receptor Agonists; Purinergic P2 Receptor Antagonists; Quinolinium Compounds; Receptors, Purinergic P2; Receptors, Purinergic P2X7; Spectrometry, Fluorescence; Time Factors

2009